Sintx Technologies (SINT) Stock Price, News & Analysis

Company Overview

Sintx Technologies, Inc. (NASDAQ: SINT) is a specialty medical device company that develops and manufactures advanced biomaterial solutions for orthopedic and reconstructive surgery. Founded in 2002 and headquartered in Ann Arbor, Michigan, Sintx has pioneered porous silicon-based and glass-derived substrate technologies designed to enhance bone healing and implant integration. The company serves a diverse customer base that includes distributors, original equipment manufacturers (OEMs) and healthcare institutions across North America, Europe and select Asian markets.

The core of Sintx’s product portfolio is its proprietary PorousSi™ platform, which features three-dimensional, interconnected pore structures intended to support cellular in-growth and vascularization. These biomaterials are used as coatings and standalone implants for spinal fusion, trauma fixation, cranio-maxillofacial reconstruction and sports medicine procedures. Sintx also offers customized device components made from medical-grade borosilicate glass and silicon-based ceramics, enabling partners to enhance existing implant designs or develop next-generation therapies.

Sintx maintains manufacturing and research operations in the United States, adhering to ISO 13485 standards and holding multiple FDA clearances for its implantable materials and devices. The company collaborates with leading academic and clinical institutions to validate performance in preclinical and clinical settings, while investing in process improvements to scale production and meet evolving regulatory requirements. Sintx’s integrated approach combines material science expertise with engineering capabilities to deliver reproducible, high-quality products.

Under the leadership of an experienced executive team, Sintx Technologies continues to focus on innovation, strategic partnerships and geographic expansion. The company’s management brings together seasoned professionals in medical device development, regulatory affairs and manufacturing operations. Looking ahead, Sintx aims to broaden its product offerings, pursue additional regulatory clearances and strengthen its position as a key supplier of advanced biomaterial solutions in the global orthopedic market.

Key Stats

• Today's Range: $2.71 to $2.83
• 50-Day Range: $2.53 to $3.47
• 52-Week Range: $1.71 to $8.60
• Volume: 43,858 shs
• Average Volume: 948,326 shs
• Market Capitalization: $6.95 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $28.00
• Consensus Rating: Buy

Sintx Technologies Stock Analysis - MarketRank™

Sintx Technologies scored higher than 71% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.5 / 5
• Analyst Rating: Buy

Consensus Rating

Sintx Technologies has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

Amount of Analyst Coverage

Sintx Technologies has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Sintx Technologies is -0.05, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Sintx Technologies is -0.05, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Sintx Technologies has a P/B Ratio of 0.96. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

4.37% of the float of Sintx Technologies has been sold short.

Short Interest Ratio / Days to Cover

Sintx Technologies has a short interest ratio ("days to cover") of 0.6, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Sintx Technologies has recently decreased by 36.20%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Sintx Technologies does not currently pay a dividend.

Dividend Growth

Sintx Technologies does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

4.37% of the float of Sintx Technologies has been sold short.

Short Interest Ratio / Days to Cover

Sintx Technologies has a short interest ratio ("days to cover") of 0.6, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Sintx Technologies has recently decreased by 36.20%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 3.8 / 5
• News Sentiment: N/A

News Sentiment

Sintx Technologies has a news sentiment score of 1.87. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.97 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 1 news article for Sintx Technologies this week, compared to 1 article on an average week.

Search Interest

1 people have searched for SINT on MarketBeat in the last 30 days.

MarketBeat Follows

2 people have added Sintx Technologies to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: Acquiring Shares

Insider Buying vs. Insider Selling

In the past three months, Sintx Technologies insiders have bought more of their company's stock than they have sold. Specifically, they have bought $62,908.00 in company stock and sold $0.00 in company stock.

Percentage Held by Insiders

Only 0.01% of the stock of Sintx Technologies is held by insiders.

Percentage Held by Institutions

Only 18.38% of the stock of Sintx Technologies is held by institutions.

SINT Stock Analysis - Frequently Asked Questions

How have SINT shares performed this year?

Sintx Technologies' stock was trading at $3.50 at the start of the year. Since then, SINT stock has decreased by 20.9% and is now trading at $2.77.

How were Sintx Technologies' earnings last quarter?

Sintx Technologies, Inc. (NASDAQ:SINT) posted its earnings results on Thursday, May, 15th. The company reported ($1.29) earnings per share for the quarter, missing analysts' consensus estimates of ($0.71) by $0.58. The firm had revenue of $0.37 million for the quarter, compared to analysts' expectations of $0.73 million. Sintx Technologies had a negative trailing twelve-month return on equity of 203.66% and a negative net margin of 483.85%.

When did Sintx Technologies' stock split?

Shares of Sintx Technologies reverse split on Tuesday, May 28th 2024.The 1-200 reverse split was announced on Tuesday, May 28th 2024. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, May 28th 2024. An investor that had 100 shares of stock prior to the reverse split would have 1 shares after the split.

Who are Sintx Technologies' major shareholders?

Sintx Technologies' top institutional investors include Veracity Capital LLC (2.89%). Insiders that own company stock include Mark Lewis Anderson, Gregg R Honigblum, Eric K Olson and David W Truetzel.
View institutional ownership trends.

How do I buy shares of Sintx Technologies?

Shares of SINT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Sintx Technologies own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Sintx Technologies investors own include Bionano Genomics (BNGO), Sorrento Therapeutics (SRNE), NightHawk Biosciences (NHWK), NIO (NIO), Citius Pharmaceuticals (CTXR), T2 Biosystems (TTOO) and Boxlight (BOXL).

Company Calendar

• Last Earnings: 5/15/2025
• Today: 7/16/2025
• Next Earnings (Estimated): 8/04/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED INSTRUMENTS
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:SINT
• CIK: 1269026
• Web: www.sintx.com
• Phone: (855) 839-3500
• Fax: N/A
• Employees: 40
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Sintx Technologies: $28.00
• High Price Target: $28.00
• Low Price Target: $28.00
• Potential Upside/Downside: +910.8%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 1 Analysts

Profitability

• EPS (Trailing Twelve Months): ($50.56)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$11.02 million
• Net Margins: -483.85%
• Pretax Margin: -483.85%
• Return on Equity: -203.66%
• Return on Assets: -104.76%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 3.44
• Quick Ratio: 3.25

Sales & Book Value

• Annual Sales: $2.89 million
• Price / Sales: 2.41
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $2.90 per share
• Price / Book: 0.96

Miscellaneous

• Outstanding Shares: 2,510,000
• Free Float: 2,509,000
• Market Cap: $6.95 million
• Optionable: Not Optionable
• Beta: 0.71